Clinical Trials Directory

Trials / Completed

CompletedNCT04323722

Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Institut Cancerologie de l'Ouest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial is assessing how Bladder filling variations and thus mesorectal movements are less when radiotherapy treatment is received with an empty bladder in rectal cancer

Detailed description

The purpose of this study is to show that the variations of bladder volume and mesorectal movements are less with empty versus filled bladder in rectal cancer. In this study, patient will be treated with 3D conformal radiotherapy (3D-CRT) radiotherapy with a filled bladder condition, as per standard care, in supine position. A total dose of 45 or 50 Gy in 25 fractions, 5 fractions per week is received. A Chest, abdomen and pelvis imaging will be performed before treatment start. Patients receive planning CT scan with filled bladder and then with empty bladder on the same day. Only planning CT scan with filled bladder will be used patient treatment. During radiotherapy treatment, patient will receive CBCTs with filled ans empty bladder on Day 1 ; 2 and 3 on the first week and once a week after. Multiple parameters will be assessed before treatment (using planning CT scan) and during radiotherapy treatment (CBCTs) in empty ans filled bladder conditions : Bladder volume, mesorectal movements. A dosimetric study will be performed in Intensity-modulated radiotherapy (IMRT) in empty and filled bladder conditions

Conditions

Interventions

TypeNameDescription
PROCEDUREEmpty Bladder planning CT scan and CBCTsPatient will receive a Planning CT scan, 3 CBCTs on the first week and once a week during radiotherapy treatment with an Empty Bladder

Timeline

Start date
2020-09-08
Primary completion
2024-09-11
Completion
2024-09-11
First posted
2020-03-26
Last updated
2024-11-07

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04323722. Inclusion in this directory is not an endorsement.